GLUD1 not only converts glutamate to α-KG but also regulates multiple signaling pathways and downstream genes to modulate the development of kidney cancer, glioblastoma, and lung cancer (Jin et al., 2015; Yang et al., 2020; Shao et al., 2022). This evidence concerns the gene GLUD1 and kidney cancer.